17.20
前日終値:
$17.05
開ける:
$16.905
24時間の取引高:
1.40M
Relative Volume:
0.43
時価総額:
$4.11B
収益:
$426.45M
当期純損益:
$197.67M
株価収益率:
20.98
EPS:
0.82
ネットキャッシュフロー:
$110.10M
1週間 パフォーマンス:
-2.77%
1か月 パフォーマンス:
-3.75%
6か月 パフォーマンス:
+3.74%
1年 パフォーマンス:
+25.00%
Adma Biologics Inc Stock (ADMA) Company Profile
ADMA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
ADMA
Adma Biologics Inc
|
17.20 | 4.07B | 426.45M | 197.67M | 110.10M | 0.82 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
476.95 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
572.39 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
325.64 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
575.42 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
294.83 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2023-07-19 | 再開されました | Raymond James | Strong Buy |
2022-10-13 | 開始されました | Mizuho | Buy |
2021-11-11 | アップグレード | Raymond James | Outperform → Strong Buy |
2021-11-09 | 開始されました | Cantor Fitzgerald | Overweight |
2019-06-04 | 開始されました | Jefferies | Buy |
2019-04-15 | 繰り返されました | H.C. Wainwright | Buy |
2019-02-07 | 再開されました | H.C. Wainwright | Buy |
2017-12-11 | 繰り返されました | Maxim Group | Buy |
2017-11-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
2017-01-23 | アップグレード | Maxim Group | Hold → Buy |
2016-08-01 | ダウングレード | Maxim Group | Buy → Hold |
2016-07-25 | 繰り返されました | Maxim Group | Buy |
2015-05-13 | 繰り返されました | Maxim Group | Buy |
2014-12-08 | 開始されました | Oppenheimer | Outperform |
2014-12-01 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Adma Biologics Inc (ADMA) 最新ニュース
Is ADMA Biologics Inc. a good long term investmentFree Consultation - Autocar Professional
Heavy Insider Selling at ADMA Biologics Despite Earnings Strength - Insider Monkey
What drives ADMA Biologics Inc. stock priceExceptional growth trajectory - Autocar Professional
ADMA Biologics Inc. Stock Analysis and ForecastConsistent triple-digit returns - jammulinksnews.com
What analysts say about ADMA Biologics Inc. stockOutstanding risk-reward balance - jammulinksnews.com
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
We Think ADMA Biologics (NASDAQ:ADMA) Can Manage Its Debt With Ease - 富途牛牛
Institutional investors in ADMA Biologics, Inc. (NASDAQ:ADMA) lost 9.6% last week but have reaped the benefits of longer-term growth - simplywall.st
Where are the Opportunities in (ADMA) - news.stocktradersdaily.com
ADMA Biologics Plunges 4.89% Amid Insider Selling Concerns - AInvest
ADMA Biologics Shares Plunge 5.84% Amid Insider Trading Concerns - AInvest
How ADMA Biologics Inc. stock performs during market volatility3x Return Stock Radar - beatles.ru
ADMA Biologics' Insider Transactions: A Strategic Exit or a Vote of Confidence? - AInvest
Adma Biologics (ADMA) Declines More Than Market: Some Information for Investors - Yahoo Finance
ADMA Biologics, Inc. Rings the Nasdaq Stock Market Opening Bell - Nasdaq
ADMA Biologics, Inc. Rings the Opening Bell - Nasdaq
Adma Biologics (ADMA) Outperforms Broader Market: What You Need to Know - Yahoo Finance
(ADMA) Proactive Strategies - news.stocktradersdaily.com
Wall Street Bulls Look Optimistic About Adma Biologics (ADMA): Should You Buy? - Yahoo Finance
(ADMA) Investment Analysis - news.stocktradersdaily.com
Adma Biologics (ADMA) Stock Drops Despite Market Gains: Important Facts to Note - MSN
Implied Volatility Surging for ADMA Biologics Stock Options - TradingView
Will Strong Asceniv Sales Drive ADMA Biologics Further? - Zacks Investment Research
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today? - Yahoo Finance
ADMA Biologics (ADMA) Drops 14.7% W/W as 3 Execs Unload Portfolios - Insider Monkey
Here's Why Adma Biologics (ADMA) Fell More Than Broader Market - Nasdaq
ADMA Biologics (ADMA) Drops for 5th Consecutive Day – Here’s Why - Insider Monkey
(ADMA) On The My Stocks Page - news.stocktradersdaily.com
ADMA Makes Notable Cross Below Critical Moving Average - Nasdaq
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales? - sharewise
ADMA Biologics: Slowing Growth Warrants A Shift To Neutral (Rating Downgrade) - Seeking Alpha
Adma Biologics Inc (ADMA) 財務データ
収益
当期純利益
現金流量
EPS
Adma Biologics Inc (ADMA) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Grossman Adam S | President and CEO |
Jul 15 '25 |
Sale |
18.66 |
21,000 |
391,860 |
2,037,850 |
大文字化:
|
ボリューム (24 時間):